Q2 2026 Holdings
Filed 2026-08-14 | 59 holdings | $604.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Anteris Technologies Global(AVR) | COM | 03675P102 | $54.6M | 5,545,984 | 9.0% |
| Cencora Inc(COR) | COM | 03073E105 | $49.1M | 173,588 | 8.1% |
| Maximus Inc(MMS) | COM | 577933104 | $38.5M | 715,267 | 6.4% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $27.7M | 13,323,431 | 4.6% |
| Globus MED Inc(GMED) | CL A | 379577208 | $23.8M | 301,816 | 3.9% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $22.9M | 436,700 | 3.8% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $22.2M | 695,315 | 3.7% |
| Waystar Hldg Corp(WAY) | COM | 946784105 | $19.0M | 925,834 | 3.1% |
| Sellas Life Sciences Group I(SLS)Put | COM NEW | 81642T209 | $18.2M | 1,230,700 | 3.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $17.9M | 480,383 | 3.0% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $16.9M | 177,118 | 2.8% |
| The Cigna Group(CI) | COM | 125523100 | $15.9M | 57,750 | 2.6% |
| Sanofi SA(SNY) | SPONSORED ADR | 80105N105 | $15.5M | 364,200 | 2.6% |
| Icon PUB LTD Co(ICLR) | SHS | G4705A100 | $15.3M | 88,186 | 2.5% |
| Viatris Inc(VTRS) | COM | 92556V106 | $15.2M | 954,299 | 2.5% |
| Cross Ctry Healthcare Inc(CCRN) | COM | 227483104 | $14.5M | 1,098,393 | 2.4% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $12.8M | 307,657 | 2.1% |
| Abbott Laboratories(ABT) | COM | 002824100 | $11.7M | 128,656 | 1.9% |
| Celcuity Inc(CELC) | COM | 15102K100 | $11.5M | 110,022 | 1.9% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $11.3M | 131,445 | 1.9% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $11.2M | 18,000 | 1.9% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $11.1M | 193,500 | 1.8% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $11.1M | 142,500 | 1.8% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $11.0M | 1,075,274 | 1.8% |
| Senseonics Hldgs Inc(SENS) | COM | 81727U303 | $9.0M | 1,592,692 | 1.5% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $8.9M | 623,130 | 1.5% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $8.6M | 1,300,000 | 1.4% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $8.1M | 97,305 | 1.3% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $7.3M | 1,921,872 | 1.2% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $6.9M | 1,003,562 | 1.1% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $6.5M | 208,500 | 1.1% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $6.2M | 1,486,175 | 1.0% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $5.8M | 59,254 | 1.0% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $5.6M | 127,808 | 0.9% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $5.3M | 539,493 | 0.9% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $5.3M | 208,557 | 0.9% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $5.2M | 73,952 | 0.9% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $4.9M | 1,078,965 | 0.8% |
| Savara Inc(SVRA) | COM | 805111101 | $3.8M | 617,675 | 0.6% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $3.5M | 2,634,137 | 0.6% |
| Aveanna Healthcare Hldgs Inc(AVAH) | COM | 05356F105 | $3.2M | 369,036 | 0.5% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $2.7M | 1,005,334 | 0.4% |
| Immunome Inc(IMNM) | COM | 45257U108 | $2.6M | 124,168 | 0.4% |
| Hims & Hers Health Inc(HIMS)Call | COM CL A | 433000106 | $2.6M | 75,000 | 0.4% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $2.6M | 529,933 | 0.4% |
| Serina Therapeutics Inc(SER) | COM SHS | 81751A108 | $1.9M | 1,000,000 | 0.3% |
| Aligos Therapeutics Inc(ALGS) | COM NEW | 01626L204 | $1.9M | 327,237 | 0.3% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $1.6M | 904,268 | 0.3% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T209 | $1.5M | 152,464 | 0.2% |
| Artivion Inc(AORT) | COM | 228903100 | $1.1M | 48,481 | 0.2% |